Biotechnology - Nektar Therapeutics

Filter

Current filters:

Nektar Therapeutics

Popular Filters

Nektar appoints Ivan Gergel as Senior Vice President, Drug Development & Chief Medical Officer

Nektar appoints Ivan Gergel as Senior Vice President, Drug Development & Chief Medical Officer

19-05-2014

US-based biopharmaceutical company Nektar Therapeutics (Nasdaq: NKTR) has announced that Ivan Gergel…

BiotechnologyBoardroomNektar TherapeuticsPharmaceuticalUSA

Nektar’s etirinotecan pegol passes Ph III interim efficacy analysis

14-01-2014

US biotech firm Nektar Therapeutics says that the Independent Data Monitoring Committee created to provide…

BiotechnologyNektar TherapeuticsOncologyResearch

Back to top